Records containing: Neurodegenerative Diseases
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-06-29A Randomized, Placebo-Controlled, Double-Blind Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation
-
CLINICAL_TRIALS study record update · 2026-06-03Global Study to Investigate Safety and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
-
CLINICAL_TRIALS study record update · 2026-04-23Effects of a ATNC MDD-V1 (TMS With Cognitive Training), for the Treatment of Mild Alzheimer Disease: a Randomized, Double-blinded, Placebo-controlled Study
-
CLINICAL_TRIALS study record update · 2026-04-22Retinal Hyperspectral Imaging in Neurodegenerative Diseases
-
CLINICAL_TRIALS study record update · 2026-04-16MAGNITUDE-2: A Phase 3, Multinational, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NTLA-2001 in Participants With Hereditary Transthyretin Amyloidosis With Polyneuropathy (ATTRv-PN)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-16Decision-making, Ethical Consent, and Interactive Dialogue in Ongoing Neurocognitive Decline - DECISION
-
CLINICAL_TRIALS study record update · 2026-03-27A Randomized, Placebo-Controlled, Double-Blind Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation
-
CLINICAL_TRIALS study record update · 2026-03-27Global Study to Investigate Safety and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
-
CLINICAL_TRIALS study record update · 2026-03-24Feasibility Study of Novel Technologies to Measure Vision-related Quality of Life in Patients With Neurodegenerative Diseases Affecting the Optic Nerve or Retina
-
CLINICAL_TRIALS study record update · 2026-03-18Investigating the Genetic Basis of Hereditary Spastic Paraplegia
-
CLINICAL_TRIALS study record update · 2026-03-13Safety and Efficacy of Allopregnanolone (Allo) as a Regenerative Therapeutic for Alzheimer's Disease: Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Clinical Trial
-
CLINICAL_TRIALS study record update · 2026-03-13Study on the Application of ¹⁸F-FCOB04, a MAO-B Targeted PET Imaging Agent, in Neurodegenerative Diseases
-
CLINICAL_TRIALS study record update · 2026-03-12NAD+ Oral Supplement Pilot Intervention in Adult Females
-
CLINICAL_TRIALS study record update · 2026-02-27An Open Label Extension of XPro1595 in Patients With Alzheimer's Disease That Have Completed a Phase 1 or Phase 2 Study With XPro1595
-
CLINICAL_TRIALS study record update · 2026-01-21A Continuation Study of Latozinemab in Participants With Neurodegenerative Disease
-
CLINICAL_TRIALS study record update · 2026-01-16Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity
-
CLINICAL_TRIALS study record update · 2025-12-30Establishment of Chinese Brain Charts for Individualized Diagnosis of Major Brain Diseases
-
CLINICAL_TRIALS study record update · 2025-12-05Validation Study of VIRADIA: A Virtual Reality Diagnostic Platform for the Assessment of Neurological and Cognitive Functions
-
CLINICAL_TRIALS study record update · 2025-12-04Evaluation of the Peripheral Nerve Ultrasound as a Diagnostic Tool in CANVAS (Cerebellar Ataxia With Neuropathy and Vestibular Areflexia Syndrome) Neuronopathies
-
CLINICAL_TRIALS study record update · 2025-11-26Brain Computer Interface Prototype Development for Assisted Alternative Communication in ALS
-
CLINICAL_TRIALS study record update · 2025-11-18Clinical Study on the Safety, Tolerance and Preliminary Efficacy of Human Mesenchymal Stem Cell Therapy for Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2025-11-14Investigating the Effect of Different Donanemab Dosing Regimens on ARIA-E and Amyloid Lowering in Adults With Early Symptomatic Alzheimer's Disease
-
CLINICAL_TRIALS study record update · 2025-11-12Cognitive Reserve and Linguistic Resilience in Bilingual Hispanics With Primary Progressive Aphasia
-
CLINICAL_TRIALS study record update · 2025-11-06Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside on Bioenergetic Metabolism, Oxidative Stress, and Cognition in Mild Cognitive Impairment and Mild Alzheimer's Dementia
-
CLINICAL_TRIALS study record update · 2025-10-08A Phase 2 Extension Study to Evaluate the Long-Term Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of AOC 1001 Administered Intravenously to Adult Myotonic Dystrophy Type 1 (DM1) Patients